An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...